Heart Disease Trial, Recruiting (NCT07235462)

Heart Disease Trial, Recruiting NCT07235462 Sponsor: Bayer Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07235462 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older at the time you sign the consent form
You must have been diagnosed with ATTR-CM (a heart condition caused by a protein called transthyretin), either the wild-type (age-related) or hereditary (inherited gene variant) form
You must have signed the official consent form agreeing to take part in the study
Your doctor must have already decided, as part of your normal care, that you should start treatment with acoramidis before you sign the consent form
You must be able to start taking acoramidis within 90 days of signing the consent form (you may also start on the same day you sign it)

Who may not be able to join:

You are currently taking part in another clinical trial that involves treatments or procedures outside of normal medical care
You have a medical reason why you should not take acoramidis, based on the official prescribing guidance for this medication in your country (confirm with trial site)
You are unable to give your own consent to take part — for example, if someone else would need to make that decision on your behalf

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (+)1-888-84 22937

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07235462

Sponsor: Bayer

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: (+)1-888-84 22937

More information: https://clinicaltrials.gov/study/NCT07235462

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older at the time you sign the consent form
You must have been diagnosed with ATTR-CM (a heart condition caused by a protein called transthyretin), either the wild-type (age-related) or hereditary (inherited gene variant) form
You must have signed the official consent form agreeing to take part in the study
Your doctor must have already decided, as part of your normal care, that you should start treatment with acoramidis before you sign the consent form
You must be able to start taking acoramidis within 90 days of signing the consent form (you may also start on the same day you sign it)

Who may not be able to join:

You are currently taking part in another clinical trial that involves treatments or procedures outside of normal medical care
You have a medical reason why you should not take acoramidis, based on the official prescribing guidance for this medication in your country (confirm with trial site)
You are unable to give your own consent to take part — for example, if someone else would need to make that decision on your behalf

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Bayer

Registry

ClinicalTrials.gov

Start date

29 October 2025

Est. completion

30 April 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Patient demographic characteristics: age; Patient demographic characteristics: sex; Patient demographic characteristics: race; Patient demographic characteristics: height; Patient demographic characteristics: weight; Clinical Characteristics: Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Type; Clinical Characteristics: Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Genetic status; Clinical Characteristics: Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Diagnosis; Clinical Characteristics: Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Setting of Diagnosis; Clinical Characteristics: Transthyre...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov